Trials / Enrolling By Invitation
Enrolling By InvitationNCT06581120
GLP_1 RA Ultrasound Study
Assessment of Gastric Contents in Patients Taking Glucagon-Like Peptide-1 Receptor Agonists: a Prospective Observational Cross-sectional Study
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Children's Hospital Medical Center, Cincinnati · Academic / Other
- Sex
- All
- Age
- 10 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to determine whether patients taking GLP-1 RAs have increased residual (left behind), gastric (stomach), contents due to delayed gastric emptying when following standard preoperative fasting guidelines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucagon-Like Peptide-1 receptor agonists | GLP-1 RAs: Glucagon like peptide-1 receptor agonists, this includes patients who are on Liraglutide, Semaglutide, Dulaglutide and Tirzepatide.Tirzepatide which is a combined GLP-1 RA/glucose-dependent insulinotropic polypeptide (GIP) agonist is included as a part of GLP-1 RAs. |
| DIAGNOSTIC_TEST | Point of Care Gastric Ultrasound | A gastric ultrasound following a standard NPO period to determine gastric contents and risk of aspiration during surgery. |
Timeline
- Start date
- 2024-07-08
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2024-09-03
- Last updated
- 2024-11-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06581120. Inclusion in this directory is not an endorsement.